In Vitro Coliform Resistance to Bioactive Compounds in Urinary Infection, Assessed in a Lab Catheterization Model
2021
Emanuel Vamanu | Laura Dorina Dinu | Cristina Mihaela Luntraru | Alexandru Suciu
Bioactive compounds and phenolic compounds are viable alternatives to antibiotics in recurrent urinary tract infections. This study aimed to use a natural functional product, based on the bioactive compounds’ composition, to inhibit the uropathogenic strains of <i>Escherichia coli</i>. <i>E.</i><i>coli</i> ATCC 25922 was used to characterize the IVCM (new in vitro catheterization model). As support for reducing bacterial proliferation, the cytotoxicity against a strain of <i>Candida albicans</i> was also determined (over 75% at 1 mg/mL). The results were correlated with the analysis of the distribution of biologically active compounds (trans-ferulic acid-268.44 ± 0.001 mg/100 g extract and an equal quantity of Trans-p-coumaric acid and rosmarinic acid). A pronounced inhibitory effect against the uropathogenic strain <i>E. coli</i> 317 (4 log copy no./mL after 72 h) was determined. The results showed a targeted response to the product for tested bacterial strains. The importance of research resulted from the easy and fast characterization of the functional product with antimicrobial effect against uropathogenic strains of <i>E. coli</i>. This study demonstrated that the proposed in vitro model was a valuable tool for assessing urinary tract infections with <i>E. coli</i>.
显示更多 [+] 显示较少 [-]